Pricing Log in Create free account

China Pharma Holdings, Inc. (CPHI) vs Citius Oncology, Inc. (CTOR)

China Pharma Holdings, Inc. and Citius Oncology, Inc. are both Drug Manufacturers Specialty & Generic companies. Citius Oncology, Inc. is the larger, with a market value of $46.5M against $22.8M — 2.0× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −114.3%) and the lower return on invested capital (−67.2% vs −7.23%). Across the 13 metrics below, China Pharma Holdings, Inc. leads on 9 and Citius Oncology, Inc. on 4.

Valuation

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 5.49 n/m 2.08
P/B 0.59 1.36 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 6.25 n/m 2.87
Earnings yield (81.13%) (92.16%) (15.94%)
Free cash flow yield (1.55%) (58.41%) 0.00%

Profitability

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
Gross margin 11.76% — 53.51%
Operating margin (111.84%) 0.00% 0.00%
Net margin (114.33%) 0.00% (2.45%)
Free cash flow margin (3.59%) 0.00% 0.00%
Return on equity (20.99%) (126.58%) (0.80%)
Return on assets (15.30%) (45.20%) (1.67%)
Return on invested capital (7.23%) (67.15%) 0.00%

Growth

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (10.97%) — 5.22%
EPS growth (last fiscal year) 72.59% (9.68%) 42.91%
Revenue growth, 5-year CAGR (17.53%) — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
Debt to equity 0.05 0.50 0.04
Current ratio 0.26 0.73 2.41
Net debt to EBITDA (0.98) (0.40) 1.01

Dividend

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CPHI CTOR Drug Manufacturers Specialty & Generic median
Market cap 22.81m 46.50m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack